NDC properties for "timolol 0.25 % Ophthalmic Gel" (RxCUI 313407)
About this data
The tables show NDC propoerties for timolol 0.25 % Ophthalmic Gel with the RxCUI 313407
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for timolol 0.25 % Ophthalmic Gel (RxCUI 313407)
| ANDA | ANDA210640 |
|---|---|
| ANDA | ANDA214645 |
| ANDA | ANDA215733 |
| ANDA | ANDA216343 |
| MMSL_CODE | BD3327 |
| MMSL_CODE | CD3327 |
| NDA | NDA020963 |
| RxCUI | 313407 |
| SNOMEDCT | 766408009 |
| SPL_SET_ID | 1f886442-2781-4be4-b20d-d22c2c209790 |
| SPL_SET_ID | 581f80f7-4419-49e2-867d-40443c75409f |
| SPL_SET_ID | 72b0d0ec-832a-4c25-b845-2537ab506354 |
| SPL_SET_ID | 79730e4f-d533-42c7-b7b6-cdbc47242baa |
| SPL_SET_ID | 9515f95c-e29b-3c7f-0bdd-cda783988a72 |
| SPL_SET_ID | ae373e96-9c96-412a-9c1d-e247b5feab5e |
| SPL_SET_ID | d987fdfa-3643-aa1d-cacd-c4f95f192ce7 |
| SPL_SET_ID | e797f7c7-0588-4627-b060-8df6bcfe3f7b |
| SPL_SET_ID | e93036c6-3120-e989-e053-2a95a90acf7f |
| VUID | 4002853 |
| Prescribable Synonym | timolol maleate 0.25 % Ophthalmic Gel Forming Solution |
| RXNAV_STR | timolol 0.0025 MG/MG Ophthalmic Gel |
| RxNorm Name | timolol 0.0025 MG/MG Ophthalmic Gel |
| RxNorm Synonym | timolol 0.25 % Ophthalmic Gel |
| RxNorm Synonym | timolol 0.25 % Ophthalmic Gel Forming Solution |
| Related queries | Interactions (for RxCUI 313407) |
NDC Properties
NDC Item 24208081825
| NDC 9 | 24208-818 |
|---|---|
| NDC 10 | 24208-818-25 |
| NDC Item | 24208081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 567541 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 24208-818 |
NDC Item 43598074711
| NDC 9 | 43598-747 |
|---|---|
| NDC 10 | 43598-747-11 |
| NDC Item | 43598074711 |
| Packaging | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 793699 |
| Labeler | Dr. Reddy's Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 43598-747 |
NDC Item 60219137703
| NDC 9 | 60219-1377 |
|---|---|
| NDC 10 | 60219-1377-3 |
| NDC Item | 60219137703 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1377-3) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-1377 |
NDC Item 60219205403
| NDC 9 | 60219-2054 |
|---|---|
| NDC 10 | 60219-2054-3 |
| NDC Item | 60219205403 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2054-3) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-2054 |
NDC Item 61314022405
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-05 |
| NDC Item | 61314022405 |
| Packaging | 5 mL in 1 BOTTLE (61314-224-05) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 61314022425
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-25 |
| NDC Item | 61314022425 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-224-25) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 62332054505
| NDC 9 | 62332-545 |
|---|---|
| NDC 10 | 62332-545-05 |
| NDC Item | 62332054505 |
| Packaging | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE |
| ANDA | ANDA212942 |
| FDA SPL set id | 599393 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-11-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-545 |
NDC Item 68083045701
| NDC 9 | 68083-457 |
|---|---|
| NDC 10 | 68083-457-01 |
| NDC Item | 68083045701 |
| Packaging | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 695465 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-457 |
NDC Item 70069024101
| NDC 9 | 70069-241 |
|---|---|
| NDC 10 | 70069-241-01 |
| NDC Item | 70069024101 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA210640 |
| COLORTEXT | WHITE(slightly viscous colorless solution) |
| Color | C48325 __ |
| FDA SPL set id | 827170 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-241 |
NDC Item 72266019901
| NDC 9 | 72266-199 |
|---|---|
| NDC 10 | 72266-199-01 |
| NDC Item | 72266019901 |
| Packaging | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 866357 |
| Labeler | FOSUN PHARMA USA INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-199 |
NDC Item 72603016201
| NDC 9 | 72603-162 |
|---|---|
| NDC 10 | 72603-162-01 |
| NDC Item | 72603016201 |
| Packaging | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 747523 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-162 |
NDC Item 82260081825
| NDC 9 | 82260-818 |
|---|---|
| NDC 10 | 82260-818-25 |
| NDC Item | 82260081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 867085 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 82260-818 |
NDC Item 24208081825
| NDC 9 | 24208-818 |
|---|---|
| NDC 10 | 24208-818-25 |
| NDC Item | 24208081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 567541 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 24208-818 |
NDC Item 43598074711
| NDC 9 | 43598-747 |
|---|---|
| NDC 10 | 43598-747-11 |
| NDC Item | 43598074711 |
| Packaging | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 793699 |
| Labeler | Dr. Reddy's Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 43598-747 |
NDC Item 60219137703
| NDC 9 | 60219-1377 |
|---|---|
| NDC 10 | 60219-1377-3 |
| NDC Item | 60219137703 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1377-3) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-1377 |
NDC Item 60219205403
| NDC 9 | 60219-2054 |
|---|---|
| NDC 10 | 60219-2054-3 |
| NDC Item | 60219205403 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2054-3) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-2054 |
NDC Item 61314022405
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-05 |
| NDC Item | 61314022405 |
| Packaging | 5 mL in 1 BOTTLE (61314-224-05) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 61314022425
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-25 |
| NDC Item | 61314022425 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-224-25) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 62332054505
| NDC 9 | 62332-545 |
|---|---|
| NDC 10 | 62332-545-05 |
| NDC Item | 62332054505 |
| Packaging | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE |
| ANDA | ANDA212942 |
| FDA SPL set id | 599393 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-11-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-545 |
NDC Item 68083045701
| NDC 9 | 68083-457 |
|---|---|
| NDC 10 | 68083-457-01 |
| NDC Item | 68083045701 |
| Packaging | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 695465 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-457 |
NDC Item 70069024101
| NDC 9 | 70069-241 |
|---|---|
| NDC 10 | 70069-241-01 |
| NDC Item | 70069024101 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA210640 |
| COLORTEXT | WHITE(slightly viscous colorless solution) |
| Color | C48325 __ |
| FDA SPL set id | 827170 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-241 |
NDC Item 72266019901
| NDC 9 | 72266-199 |
|---|---|
| NDC 10 | 72266-199-01 |
| NDC Item | 72266019901 |
| Packaging | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 866357 |
| Labeler | FOSUN PHARMA USA INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-199 |
NDC Item 72603016201
| NDC 9 | 72603-162 |
|---|---|
| NDC 10 | 72603-162-01 |
| NDC Item | 72603016201 |
| Packaging | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 747523 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-162 |
NDC Item 82260081825
| NDC 9 | 82260-818 |
|---|---|
| NDC 10 | 82260-818-25 |
| NDC Item | 82260081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 867085 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 82260-818 |
NDC Item 24208081825
| NDC 9 | 24208-818 |
|---|---|
| NDC 10 | 24208-818-25 |
| NDC Item | 24208081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 567541 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 24208-818 |
NDC Item 43598074711
| NDC 9 | 43598-747 |
|---|---|
| NDC 10 | 43598-747-11 |
| NDC Item | 43598074711 |
| Packaging | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 793699 |
| Labeler | Dr. Reddy's Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 43598-747 |
NDC Item 60219137703
| NDC 9 | 60219-1377 |
|---|---|
| NDC 10 | 60219-1377-3 |
| NDC Item | 60219137703 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1377-3) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-1377 |
NDC Item 60219205403
| NDC 9 | 60219-2054 |
|---|---|
| NDC 10 | 60219-2054-3 |
| NDC Item | 60219205403 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2054-3) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-2054 |
NDC Item 61314022405
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-05 |
| NDC Item | 61314022405 |
| Packaging | 5 mL in 1 BOTTLE (61314-224-05) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 61314022425
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-25 |
| NDC Item | 61314022425 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-224-25) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 62332054505
| NDC 9 | 62332-545 |
|---|---|
| NDC 10 | 62332-545-05 |
| NDC Item | 62332054505 |
| Packaging | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE |
| ANDA | ANDA212942 |
| FDA SPL set id | 599393 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-11-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-545 |
NDC Item 68083045701
| NDC 9 | 68083-457 |
|---|---|
| NDC 10 | 68083-457-01 |
| NDC Item | 68083045701 |
| Packaging | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 695465 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-457 |
NDC Item 70069024101
| NDC 9 | 70069-241 |
|---|---|
| NDC 10 | 70069-241-01 |
| NDC Item | 70069024101 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA210640 |
| COLORTEXT | WHITE(slightly viscous colorless solution) |
| Color | C48325 __ |
| FDA SPL set id | 827170 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-241 |
NDC Item 72266019901
| NDC 9 | 72266-199 |
|---|---|
| NDC 10 | 72266-199-01 |
| NDC Item | 72266019901 |
| Packaging | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 866357 |
| Labeler | FOSUN PHARMA USA INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-199 |
NDC Item 72603016201
| NDC 9 | 72603-162 |
|---|---|
| NDC 10 | 72603-162-01 |
| NDC Item | 72603016201 |
| Packaging | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 747523 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-162 |
NDC Item 82260081825
| NDC 9 | 82260-818 |
|---|---|
| NDC 10 | 82260-818-25 |
| NDC Item | 82260081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 867085 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 82260-818 |
NDC Item 24208081825
| NDC 9 | 24208-818 |
|---|---|
| NDC 10 | 24208-818-25 |
| NDC Item | 24208081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 567541 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 24208-818 |
NDC Item 43598074711
| NDC 9 | 43598-747 |
|---|---|
| NDC 10 | 43598-747-11 |
| NDC Item | 43598074711 |
| Packaging | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 793699 |
| Labeler | Dr. Reddy's Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 43598-747 |
NDC Item 60219137703
| NDC 9 | 60219-1377 |
|---|---|
| NDC 10 | 60219-1377-3 |
| NDC Item | 60219137703 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1377-3) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-1377 |
NDC Item 60219205403
| NDC 9 | 60219-2054 |
|---|---|
| NDC 10 | 60219-2054-3 |
| NDC Item | 60219205403 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2054-3) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-2054 |
NDC Item 61314022405
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-05 |
| NDC Item | 61314022405 |
| Packaging | 5 mL in 1 BOTTLE (61314-224-05) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 61314022425
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-25 |
| NDC Item | 61314022425 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-224-25) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 62332054505
| NDC 9 | 62332-545 |
|---|---|
| NDC 10 | 62332-545-05 |
| NDC Item | 62332054505 |
| Packaging | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE |
| ANDA | ANDA212942 |
| FDA SPL set id | 599393 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-11-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-545 |
NDC Item 68083045701
| NDC 9 | 68083-457 |
|---|---|
| NDC 10 | 68083-457-01 |
| NDC Item | 68083045701 |
| Packaging | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 695465 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-457 |
NDC Item 70069024101
| NDC 9 | 70069-241 |
|---|---|
| NDC 10 | 70069-241-01 |
| NDC Item | 70069024101 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA210640 |
| COLORTEXT | WHITE(slightly viscous colorless solution) |
| Color | C48325 __ |
| FDA SPL set id | 827170 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-241 |
NDC Item 72266019901
| NDC 9 | 72266-199 |
|---|---|
| NDC 10 | 72266-199-01 |
| NDC Item | 72266019901 |
| Packaging | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 866357 |
| Labeler | FOSUN PHARMA USA INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-199 |
NDC Item 72603016201
| NDC 9 | 72603-162 |
|---|---|
| NDC 10 | 72603-162-01 |
| NDC Item | 72603016201 |
| Packaging | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 747523 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-162 |
NDC Item 82260081825
| NDC 9 | 82260-818 |
|---|---|
| NDC 10 | 82260-818-25 |
| NDC Item | 82260081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 867085 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 82260-818 |
NDC Item 24208081825
| NDC 9 | 24208-818 |
|---|---|
| NDC 10 | 24208-818-25 |
| NDC Item | 24208081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 567541 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 24208-818 |
NDC Item 43598074711
| NDC 9 | 43598-747 |
|---|---|
| NDC 10 | 43598-747-11 |
| NDC Item | 43598074711 |
| Packaging | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 793699 |
| Labeler | Dr. Reddy's Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 43598-747 |
NDC Item 60219137703
| NDC 9 | 60219-1377 |
|---|---|
| NDC 10 | 60219-1377-3 |
| NDC Item | 60219137703 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1377-3) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-1377 |
NDC Item 60219205403
| NDC 9 | 60219-2054 |
|---|---|
| NDC 10 | 60219-2054-3 |
| NDC Item | 60219205403 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2054-3) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-2054 |
NDC Item 61314022405
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-05 |
| NDC Item | 61314022405 |
| Packaging | 5 mL in 1 BOTTLE (61314-224-05) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 61314022425
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-25 |
| NDC Item | 61314022425 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-224-25) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 62332054505
| NDC 9 | 62332-545 |
|---|---|
| NDC 10 | 62332-545-05 |
| NDC Item | 62332054505 |
| Packaging | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE |
| ANDA | ANDA212942 |
| FDA SPL set id | 599393 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-11-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-545 |
NDC Item 68083045701
| NDC 9 | 68083-457 |
|---|---|
| NDC 10 | 68083-457-01 |
| NDC Item | 68083045701 |
| Packaging | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 695465 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-457 |
NDC Item 70069024101
| NDC 9 | 70069-241 |
|---|---|
| NDC 10 | 70069-241-01 |
| NDC Item | 70069024101 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA210640 |
| COLORTEXT | WHITE(slightly viscous colorless solution) |
| Color | C48325 __ |
| FDA SPL set id | 827170 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-241 |
NDC Item 72266019901
| NDC 9 | 72266-199 |
|---|---|
| NDC 10 | 72266-199-01 |
| NDC Item | 72266019901 |
| Packaging | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 866357 |
| Labeler | FOSUN PHARMA USA INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-199 |
NDC Item 72603016201
| NDC 9 | 72603-162 |
|---|---|
| NDC 10 | 72603-162-01 |
| NDC Item | 72603016201 |
| Packaging | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 747523 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-162 |
NDC Item 82260081825
| NDC 9 | 82260-818 |
|---|---|
| NDC 10 | 82260-818-25 |
| NDC Item | 82260081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 867085 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 82260-818 |
NDC Item 24208081825
| NDC 9 | 24208-818 |
|---|---|
| NDC 10 | 24208-818-25 |
| NDC Item | 24208081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 567541 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 24208-818 |
NDC Item 43598074711
| NDC 9 | 43598-747 |
|---|---|
| NDC 10 | 43598-747-11 |
| NDC Item | 43598074711 |
| Packaging | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 793699 |
| Labeler | Dr. Reddy's Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 43598-747 |
NDC Item 60219137703
| NDC 9 | 60219-1377 |
|---|---|
| NDC 10 | 60219-1377-3 |
| NDC Item | 60219137703 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1377-3) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-1377 |
NDC Item 60219205403
| NDC 9 | 60219-2054 |
|---|---|
| NDC 10 | 60219-2054-3 |
| NDC Item | 60219205403 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2054-3) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-2054 |
NDC Item 61314022405
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-05 |
| NDC Item | 61314022405 |
| Packaging | 5 mL in 1 BOTTLE (61314-224-05) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 61314022425
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-25 |
| NDC Item | 61314022425 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-224-25) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 62332054505
| NDC 9 | 62332-545 |
|---|---|
| NDC 10 | 62332-545-05 |
| NDC Item | 62332054505 |
| Packaging | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE |
| ANDA | ANDA212942 |
| FDA SPL set id | 599393 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-11-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-545 |
NDC Item 68083045701
| NDC 9 | 68083-457 |
|---|---|
| NDC 10 | 68083-457-01 |
| NDC Item | 68083045701 |
| Packaging | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 695465 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-457 |
NDC Item 70069024101
| NDC 9 | 70069-241 |
|---|---|
| NDC 10 | 70069-241-01 |
| NDC Item | 70069024101 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA210640 |
| COLORTEXT | WHITE(slightly viscous colorless solution) |
| Color | C48325 __ |
| FDA SPL set id | 827170 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-241 |
NDC Item 72266019901
| NDC 9 | 72266-199 |
|---|---|
| NDC 10 | 72266-199-01 |
| NDC Item | 72266019901 |
| Packaging | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 866357 |
| Labeler | FOSUN PHARMA USA INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-199 |
NDC Item 72603016201
| NDC 9 | 72603-162 |
|---|---|
| NDC 10 | 72603-162-01 |
| NDC Item | 72603016201 |
| Packaging | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 747523 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-162 |
NDC Item 82260081825
| NDC 9 | 82260-818 |
|---|---|
| NDC 10 | 82260-818-25 |
| NDC Item | 82260081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 867085 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 82260-818 |
NDC Item 24208081825
| NDC 9 | 24208-818 |
|---|---|
| NDC 10 | 24208-818-25 |
| NDC Item | 24208081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 567541 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 24208-818 |
NDC Item 43598074711
| NDC 9 | 43598-747 |
|---|---|
| NDC 10 | 43598-747-11 |
| NDC Item | 43598074711 |
| Packaging | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 793699 |
| Labeler | Dr. Reddy's Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 43598-747 |
NDC Item 60219137703
| NDC 9 | 60219-1377 |
|---|---|
| NDC 10 | 60219-1377-3 |
| NDC Item | 60219137703 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1377-3) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-1377 |
NDC Item 60219205403
| NDC 9 | 60219-2054 |
|---|---|
| NDC 10 | 60219-2054-3 |
| NDC Item | 60219205403 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2054-3) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-2054 |
NDC Item 61314022405
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-05 |
| NDC Item | 61314022405 |
| Packaging | 5 mL in 1 BOTTLE (61314-224-05) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 61314022425
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-25 |
| NDC Item | 61314022425 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-224-25) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 62332054505
| NDC 9 | 62332-545 |
|---|---|
| NDC 10 | 62332-545-05 |
| NDC Item | 62332054505 |
| Packaging | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE |
| ANDA | ANDA212942 |
| FDA SPL set id | 599393 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-11-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-545 |
NDC Item 68083045701
| NDC 9 | 68083-457 |
|---|---|
| NDC 10 | 68083-457-01 |
| NDC Item | 68083045701 |
| Packaging | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 695465 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-457 |
NDC Item 70069024101
| NDC 9 | 70069-241 |
|---|---|
| NDC 10 | 70069-241-01 |
| NDC Item | 70069024101 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA210640 |
| COLORTEXT | WHITE(slightly viscous colorless solution) |
| Color | C48325 __ |
| FDA SPL set id | 827170 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-241 |
NDC Item 72266019901
| NDC 9 | 72266-199 |
|---|---|
| NDC 10 | 72266-199-01 |
| NDC Item | 72266019901 |
| Packaging | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 866357 |
| Labeler | FOSUN PHARMA USA INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-199 |
NDC Item 72603016201
| NDC 9 | 72603-162 |
|---|---|
| NDC 10 | 72603-162-01 |
| NDC Item | 72603016201 |
| Packaging | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 747523 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-162 |
NDC Item 82260081825
| NDC 9 | 82260-818 |
|---|---|
| NDC 10 | 82260-818-25 |
| NDC Item | 82260081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 867085 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 82260-818 |
NDC Item 24208081825
| NDC 9 | 24208-818 |
|---|---|
| NDC 10 | 24208-818-25 |
| NDC Item | 24208081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 567541 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 24208-818 |
NDC Item 43598074711
| NDC 9 | 43598-747 |
|---|---|
| NDC 10 | 43598-747-11 |
| NDC Item | 43598074711 |
| Packaging | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 793699 |
| Labeler | Dr. Reddy's Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 43598-747 |
NDC Item 60219137703
| NDC 9 | 60219-1377 |
|---|---|
| NDC 10 | 60219-1377-3 |
| NDC Item | 60219137703 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1377-3) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-1377 |
NDC Item 60219205403
| NDC 9 | 60219-2054 |
|---|---|
| NDC 10 | 60219-2054-3 |
| NDC Item | 60219205403 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2054-3) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-2054 |
NDC Item 61314022405
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-05 |
| NDC Item | 61314022405 |
| Packaging | 5 mL in 1 BOTTLE (61314-224-05) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 61314022425
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-25 |
| NDC Item | 61314022425 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-224-25) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 62332054505
| NDC 9 | 62332-545 |
|---|---|
| NDC 10 | 62332-545-05 |
| NDC Item | 62332054505 |
| Packaging | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE |
| ANDA | ANDA212942 |
| FDA SPL set id | 599393 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-11-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-545 |
NDC Item 68083045701
| NDC 9 | 68083-457 |
|---|---|
| NDC 10 | 68083-457-01 |
| NDC Item | 68083045701 |
| Packaging | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 695465 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-457 |
NDC Item 70069024101
| NDC 9 | 70069-241 |
|---|---|
| NDC 10 | 70069-241-01 |
| NDC Item | 70069024101 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA210640 |
| COLORTEXT | WHITE(slightly viscous colorless solution) |
| Color | C48325 __ |
| FDA SPL set id | 827170 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-241 |
NDC Item 72266019901
| NDC 9 | 72266-199 |
|---|---|
| NDC 10 | 72266-199-01 |
| NDC Item | 72266019901 |
| Packaging | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 866357 |
| Labeler | FOSUN PHARMA USA INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-199 |
NDC Item 72603016201
| NDC 9 | 72603-162 |
|---|---|
| NDC 10 | 72603-162-01 |
| NDC Item | 72603016201 |
| Packaging | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 747523 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-162 |
NDC Item 82260081825
| NDC 9 | 82260-818 |
|---|---|
| NDC 10 | 82260-818-25 |
| NDC Item | 82260081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 867085 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 82260-818 |
NDC Item 24208081825
| NDC 9 | 24208-818 |
|---|---|
| NDC 10 | 24208-818-25 |
| NDC Item | 24208081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 567541 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 24208-818 |
NDC Item 43598074711
| NDC 9 | 43598-747 |
|---|---|
| NDC 10 | 43598-747-11 |
| NDC Item | 43598074711 |
| Packaging | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 793699 |
| Labeler | Dr. Reddy's Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 43598-747 |
NDC Item 60219137703
| NDC 9 | 60219-1377 |
|---|---|
| NDC 10 | 60219-1377-3 |
| NDC Item | 60219137703 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1377-3) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-1377 |
NDC Item 60219205403
| NDC 9 | 60219-2054 |
|---|---|
| NDC 10 | 60219-2054-3 |
| NDC Item | 60219205403 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2054-3) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-2054 |
NDC Item 61314022405
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-05 |
| NDC Item | 61314022405 |
| Packaging | 5 mL in 1 BOTTLE (61314-224-05) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 61314022425
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-25 |
| NDC Item | 61314022425 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-224-25) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 62332054505
| NDC 9 | 62332-545 |
|---|---|
| NDC 10 | 62332-545-05 |
| NDC Item | 62332054505 |
| Packaging | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE |
| ANDA | ANDA212942 |
| FDA SPL set id | 599393 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-11-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-545 |
NDC Item 68083045701
| NDC 9 | 68083-457 |
|---|---|
| NDC 10 | 68083-457-01 |
| NDC Item | 68083045701 |
| Packaging | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 695465 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-457 |
NDC Item 70069024101
| NDC 9 | 70069-241 |
|---|---|
| NDC 10 | 70069-241-01 |
| NDC Item | 70069024101 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA210640 |
| COLORTEXT | WHITE(slightly viscous colorless solution) |
| Color | C48325 __ |
| FDA SPL set id | 827170 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-241 |
NDC Item 72266019901
| NDC 9 | 72266-199 |
|---|---|
| NDC 10 | 72266-199-01 |
| NDC Item | 72266019901 |
| Packaging | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 866357 |
| Labeler | FOSUN PHARMA USA INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-199 |
NDC Item 72603016201
| NDC 9 | 72603-162 |
|---|---|
| NDC 10 | 72603-162-01 |
| NDC Item | 72603016201 |
| Packaging | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 747523 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-162 |
NDC Item 82260081825
| NDC 9 | 82260-818 |
|---|---|
| NDC 10 | 82260-818-25 |
| NDC Item | 82260081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 867085 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 82260-818 |
NDC Item 24208081825
| NDC 9 | 24208-818 |
|---|---|
| NDC 10 | 24208-818-25 |
| NDC Item | 24208081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 567541 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 24208-818 |
NDC Item 43598074711
| NDC 9 | 43598-747 |
|---|---|
| NDC 10 | 43598-747-11 |
| NDC Item | 43598074711 |
| Packaging | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 793699 |
| Labeler | Dr. Reddy's Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 43598-747 |
NDC Item 60219137703
| NDC 9 | 60219-1377 |
|---|---|
| NDC 10 | 60219-1377-3 |
| NDC Item | 60219137703 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1377-3) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-1377 |
NDC Item 60219205403
| NDC 9 | 60219-2054 |
|---|---|
| NDC 10 | 60219-2054-3 |
| NDC Item | 60219205403 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2054-3) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-2054 |
NDC Item 61314022405
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-05 |
| NDC Item | 61314022405 |
| Packaging | 5 mL in 1 BOTTLE (61314-224-05) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 61314022425
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-25 |
| NDC Item | 61314022425 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-224-25) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 62332054505
| NDC 9 | 62332-545 |
|---|---|
| NDC 10 | 62332-545-05 |
| NDC Item | 62332054505 |
| Packaging | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE |
| ANDA | ANDA212942 |
| FDA SPL set id | 599393 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-11-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-545 |
NDC Item 68083045701
| NDC 9 | 68083-457 |
|---|---|
| NDC 10 | 68083-457-01 |
| NDC Item | 68083045701 |
| Packaging | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 695465 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-457 |
NDC Item 70069024101
| NDC 9 | 70069-241 |
|---|---|
| NDC 10 | 70069-241-01 |
| NDC Item | 70069024101 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA210640 |
| COLORTEXT | WHITE(slightly viscous colorless solution) |
| Color | C48325 __ |
| FDA SPL set id | 827170 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-241 |
NDC Item 72266019901
| NDC 9 | 72266-199 |
|---|---|
| NDC 10 | 72266-199-01 |
| NDC Item | 72266019901 |
| Packaging | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 866357 |
| Labeler | FOSUN PHARMA USA INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-199 |
NDC Item 72603016201
| NDC 9 | 72603-162 |
|---|---|
| NDC 10 | 72603-162-01 |
| NDC Item | 72603016201 |
| Packaging | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 747523 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-162 |
NDC Item 82260081825
| NDC 9 | 82260-818 |
|---|---|
| NDC 10 | 82260-818-25 |
| NDC Item | 82260081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 867085 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 82260-818 |
NDC Item 24208081825
| NDC 9 | 24208-818 |
|---|---|
| NDC 10 | 24208-818-25 |
| NDC Item | 24208081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 567541 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 24208-818 |
NDC Item 43598074711
| NDC 9 | 43598-747 |
|---|---|
| NDC 10 | 43598-747-11 |
| NDC Item | 43598074711 |
| Packaging | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 793699 |
| Labeler | Dr. Reddy's Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 43598-747 |
NDC Item 60219137703
| NDC 9 | 60219-1377 |
|---|---|
| NDC 10 | 60219-1377-3 |
| NDC Item | 60219137703 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1377-3) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-1377 |
NDC Item 60219205403
| NDC 9 | 60219-2054 |
|---|---|
| NDC 10 | 60219-2054-3 |
| NDC Item | 60219205403 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2054-3) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-2054 |
NDC Item 61314022405
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-05 |
| NDC Item | 61314022405 |
| Packaging | 5 mL in 1 BOTTLE (61314-224-05) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 61314022425
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-25 |
| NDC Item | 61314022425 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-224-25) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 62332054505
| NDC 9 | 62332-545 |
|---|---|
| NDC 10 | 62332-545-05 |
| NDC Item | 62332054505 |
| Packaging | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE |
| ANDA | ANDA212942 |
| FDA SPL set id | 599393 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-11-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-545 |
NDC Item 68083045701
| NDC 9 | 68083-457 |
|---|---|
| NDC 10 | 68083-457-01 |
| NDC Item | 68083045701 |
| Packaging | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 695465 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-457 |
NDC Item 70069024101
| NDC 9 | 70069-241 |
|---|---|
| NDC 10 | 70069-241-01 |
| NDC Item | 70069024101 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA210640 |
| COLORTEXT | WHITE(slightly viscous colorless solution) |
| Color | C48325 __ |
| FDA SPL set id | 827170 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-241 |
NDC Item 72266019901
| NDC 9 | 72266-199 |
|---|---|
| NDC 10 | 72266-199-01 |
| NDC Item | 72266019901 |
| Packaging | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 866357 |
| Labeler | FOSUN PHARMA USA INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-199 |
NDC Item 72603016201
| NDC 9 | 72603-162 |
|---|---|
| NDC 10 | 72603-162-01 |
| NDC Item | 72603016201 |
| Packaging | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 747523 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-162 |
NDC Item 82260081825
| NDC 9 | 82260-818 |
|---|---|
| NDC 10 | 82260-818-25 |
| NDC Item | 82260081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 867085 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 82260-818 |
NDC Item 24208081825
| NDC 9 | 24208-818 |
|---|---|
| NDC 10 | 24208-818-25 |
| NDC Item | 24208081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (24208-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 567541 |
| Labeler | Bausch & Lomb Incorporated |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 24208-818 |
NDC Item 43598074711
| NDC 9 | 43598-747 |
|---|---|
| NDC 10 | 43598-747-11 |
| NDC Item | 43598074711 |
| Packaging | 1 BOTTLE in 1 CARTON (43598-747-11) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 793699 |
| Labeler | Dr. Reddy's Laboratories, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-05-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 43598-747 |
NDC Item 60219137703
| NDC 9 | 60219-1377 |
|---|---|
| NDC 10 | 60219-1377-3 |
| NDC Item | 60219137703 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-1377-3) / 5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-1377 |
NDC Item 60219205403
| NDC 9 | 60219-2054 |
|---|---|
| NDC 10 | 60219-2054-3 |
| NDC Item | 60219205403 |
| Packaging | 1 BOTTLE, DROPPER in 1 CARTON (60219-2054-3) / 2.5 mL in 1 BOTTLE, DROPPER |
| ANDA | ANDA216343 |
| FDA SPL set id | 801975 |
| Labeler | Amneal Pharmaceuticals NY LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-05-27 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 60219-2054 |
NDC Item 61314022405
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-05 |
| NDC Item | 61314022405 |
| Packaging | 5 mL in 1 BOTTLE (61314-224-05) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 61314022425
| NDC 9 | 61314-224 |
|---|---|
| NDC 10 | 61314-224-25 |
| NDC Item | 61314022425 |
| Packaging | 2.5 mL in 1 BOTTLE (61314-224-25) |
| FDA SPL set id | 790292 |
| Labeler | Sandoz Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 1998-12-24 |
| Marketing status | ACTIVE |
| NDA | NDA020963 |
| Related queries | Properties for NDC 9 61314-224 |
NDC Item 62332054505
| NDC 9 | 62332-545 |
|---|---|
| NDC 10 | 62332-545-05 |
| NDC Item | 62332054505 |
| Packaging | 1 BOTTLE in 1 CARTON (62332-545-05) / 5 mL in 1 BOTTLE |
| ANDA | ANDA212942 |
| FDA SPL set id | 599393 |
| Labeler | Alembic Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-11-22 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 62332-545 |
NDC Item 68083045701
| NDC 9 | 68083-457 |
|---|---|
| NDC 10 | 68083-457-01 |
| NDC Item | 68083045701 |
| Packaging | 1 BOTTLE in 1 CARTON (68083-457-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 695465 |
| Labeler | Gland Pharma Limited |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 68083-457 |
NDC Item 70069024101
| NDC 9 | 70069-241 |
|---|---|
| NDC 10 | 70069-241-01 |
| NDC Item | 70069024101 |
| Packaging | 1 BOTTLE in 1 CARTON (70069-241-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA210640 |
| COLORTEXT | WHITE(slightly viscous colorless solution) |
| Color | C48325 __ |
| FDA SPL set id | 827170 |
| Labeler | Somerset Therapeutics, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-10-31 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 70069-241 |
NDC Item 72266019901
| NDC 9 | 72266-199 |
|---|---|
| NDC 10 | 72266-199-01 |
| NDC Item | 72266019901 |
| Packaging | 1 BOTTLE in 1 CARTON (72266-199-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA214645 |
| FDA SPL set id | 866357 |
| Labeler | FOSUN PHARMA USA INC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-06-24 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72266-199 |
NDC Item 72603016201
| NDC 9 | 72603-162 |
|---|---|
| NDC 10 | 72603-162-01 |
| NDC Item | 72603016201 |
| Packaging | 1 BOTTLE in 1 CARTON (72603-162-01) / 5 mL in 1 BOTTLE |
| ANDA | ANDA215733 |
| FDA SPL set id | 747523 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2023-08-14 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 72603-162 |
NDC Item 82260081825
| NDC 9 | 82260-818 |
|---|---|
| NDC 10 | 82260-818-25 |
| NDC Item | 82260081825 |
| Packaging | 1 BOTTLE, DISPENSING in 1 CARTON (82260-818-25) / 5 mL in 1 BOTTLE, DISPENSING |
| FDA SPL set id | 867085 |
| Labeler | Bausch & Lomb Americas Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-02-14 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA020330 |
| Related queries | Properties for NDC 9 82260-818 |